Treatment with intensity-modulated radiation therapy (IMRT) for breast                cancer

Marta, G.N.; Hanna, SA; Gadia, Rafael

doi:10.1590/1806-9282.60.06.005

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Especially forward IMRT, using tangential bream angels and creating multiple segment, can be accepted as standard approach in clinical practice taking into the considerations of acute toxicity [40,41]. The published literature of forward or inverse IMRT use in clinical practice of breast cancer, has mainly focusing on toxicities and have short follow-up time.…”

Section: Imrtmentioning

confidence: 99%

Modern Radiotherapy Era in Breast Cancer

Bölükbaşı¹,

Selek²

2017

Breast Cancer - From Biology to Medicine

View full text Add to dashboard Cite

Radiation therapy (RT) is one of the major treatment modalities that are used in breast cancer treatment, and depending on the chest-wall anatomy, RT fields have to be customized. Techniques used in planning have been evolving since last two decades from two dimensional (2D) to three-dimensional (3D), while intensity modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and even proton therapy have been an option in daily approach. In addition, technological hardware and software advances in delivery and planning systems, total treatment duration of breast RT have been shortened in last decades along with recent hypofractionated radiotherapy schemes or emerging partial-breast irradiation protocols. The other attractive approach-accelerated partial breast irradiation (APBI) could be a reasonable option for highly selected subpopulation of early-stage breast cancer patients out of a clinical trial. Long-term follow-up results have emerged heart and coronary sparing with maximum safety and efficacy. The most important advance could be named as cardiac sparing-deep breathhold approach-in all the modern technique improvement. Although most advanced techniques in management of breast cancer have not been verified to increase survival, we suggest recommending resource stratified advanced in order to provide best technical and clinical care in this long-term survivor candidates.

show abstract

Section: Imrtmentioning

confidence: 99%